n-methylaspartate has been researched along with Cerebrovascular Disorders in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (88.89) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, KA; Buchan, AM; Huang, ZG; Lesiuk, H; Li, H; Smith, KE; Xue, D | 1 |
Hamberg, L; Jiang, H; Lo, EH; Matsumoto, K; Pan, Y | 1 |
Fisher, M; Jonas, S; Jones S [corrected to Jonas, S]; Sacco, RL | 1 |
Johnston, MV; Taylor, GA; Traystman, RJ; Trescher, WA | 1 |
Auer, RN | 1 |
McBurney, RN | 1 |
Loftus, CM; Robertson, SC | 1 |
Chandler, LJ; Crews, FT; Day, A; Steck, JC; Yu, CJ | 1 |
Armstead, WM; Kulkarni, M | 1 |
2 review(s) available for n-methylaspartate and Cerebrovascular Disorders
Article | Year |
---|---|
Prophylactic neuroprotection for cerebral ischemia.
Topics: Cerebrovascular Disorders; Coronary Artery Bypass; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; N-Methylaspartate; Nervous System Diseases; Nimodipine; Randomized Controlled Trials as Topic | 1994 |
Development of the NMDA ion-channel blocker, aptiganel hydrochloride, as a neuroprotective agent for acute CNS injury.
Topics: Acute Disease; Brain Injuries; Cerebrovascular Disorders; Clinical Trials as Topic; Drugs, Investigational; Glasgow Coma Scale; Guanidines; Humans; N-Methylaspartate; Neuroprotective Agents; Reference Values; Spinal Cord Injuries | 1997 |
7 other study(ies) available for n-methylaspartate and Cerebrovascular Disorders
Article | Year |
---|---|
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Cerebral Infarction; Cerebrovascular Disorders; Dizocilpine Maleate; Drug Administration Schedule; Injections, Intraperitoneal; Male; N-Methylaspartate; Quinoxalines; Rats; Rats, Wistar; Reperfusion | 1993 |
Quantitative and dynamic MRI of neuroprotection in experimental stroke.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Coloring Agents; Disease Models, Animal; Dizocilpine Maleate; Magnetic Resonance Imaging; N-Methylaspartate; Neurons; Neuroprotective Agents; Rabbits; Tetrazolium Salts | 1995 |
Acute experimental neuronal injury in the newborn lamb: US characterization and demonstration of hemodynamic effects.
Topics: Acute Disease; Animals; Animals, Newborn; Blood Flow Velocity; Brain; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Echoencephalography; Hemodynamics; N-Methylaspartate; Oxygen Consumption; Sheep | 1993 |
Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats.
Topics: Age Factors; Animals; Brain; Cerebrovascular Disorders; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Gyrus Cinguli; Humans; Male; N-Methylaspartate; Necrosis; Neurons; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sex Characteristics; Sex Factors | 1996 |
Effect of N-methyl-D-aspartate and inhibition of neuronal nitric oxide on collateral cerebral blood flow after middle cerebral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Cerebrovascular Circulation; Cerebrovascular Disorders; Collateral Circulation; Dogs; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Hemodynamics; Indazoles; N-Methylaspartate; Neurons; Nitric Oxide | 1998 |
Ethanol, stroke, brain damage, and excitotoxicity.
Topics: Animals; Autoradiography; Body Temperature; Brain; Brain Ischemia; Cells, Cultured; Central Nervous System Depressants; Cerebrovascular Disorders; Ethanol; Excitatory Amino Acid Agonists; Gerbillinae; Hippocampus; Male; N-Methylaspartate; Neurons; Nitric Oxide Synthase; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1998 |
Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury.
Topics: Animals; Animals, Newborn; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Cyclooxygenase Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acids; Female; Indomethacin; Male; N-Methylaspartate; Nitroblue Tetrazolium; Nociceptin; Opioid Peptides; Prostaglandin-Endoperoxide Synthases; Superoxide Dismutase; Vasodilation | 2000 |